Approval · Notice of Compliance 29415 · 2022
HYDREA: Notice of Compliance 29415
Issued November 8, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29415
- Date
- November 8, 2022
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDREA | 00465283 | Marketed |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP